May 2013

Ovarian stimulation in cancer patients

When performing ovarian stimulation for fertility preservation in cancer patients it is critical to understand time constraints, potential complications, risks, and the limited time opportunity.
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Like

Authors

Hakan Cakmak, M.D., Mitchell P. Rosen, M.D.

Volume 99, Issue 6, Pages 1476-1484, May 2013

Abstract

The patients referred for fertility preservation due to a malignant disease do not represent the typical population of subfertile patients treated in the in vitro fertilization units. Cancer may affect multiple tissues throughout the body and can result in variety of complications during controlled ovarian stimulation. Determination of the controlled ovarian stimulation protocol and gonadotropin dose for oocyte/embryo cryopreservation requires an individualized assessment. In this review, we highlight the new protocols that are emerging to reduce time constraints and emphasize management considerations to decrease complications.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00445-7/fulltext


Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.

Sign In Register

Recommended Content